Screener
Exagen Inc. XGN Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Exagen Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 9:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001274737-26-000029
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest expense | (1,267) | (545) |
| Change in fair value of warrant liability | 882 | — |
| Other income (expense), net | (132) | 158 |
| Loss before income taxes | (3,931) | (3,752) |
| Income tax expense | (36) | — |
| Net loss | $(3,967) | $(3,752) |
| Net loss per share, basic and diluted | $(0.17) | $(0.20) |
| Weighted-average number of shares used to compute net loss per share, basic and diluted | 23,854,997 | 18,557,390 |
Item 1. Financial Statements
FAQ
- What is Exagen Inc.'s net income?
- Exagen Inc. (XGN) reported net income of -$3.97M in Q1 2026.
- How has Exagen Inc.'s net income changed year-over-year?
- Exagen Inc.'s net income decreased by 5.7% year-over-year, from -$3.75M to -$3.97M.
- What is the long-term trend for Exagen Inc.'s net income?
- Over 4 years (2021 to 2025), Exagen Inc.'s net income has grown at a -7.2% compound annual growth rate (CAGR), from -$26.85M to -$19.95M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Exagen Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude